Device / Technology News

RSS

Stereotaxis showcases its remote magnetic navigation technology at TCT symposium

Stereotaxis, Inc. is showcasing the value of its technologies for interventional procedures at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in San Francisco this week.

24 Sep 2009

Everolimus-eluting stent efficient in treating native coronary artery lesions

Late-breaking data from SPIRIT IV, a large-scale multi-center study of nearly 4,000 patients in the U.S., shows that an everolimus-eluting stent demonstrated enhanced safety and efficacy in the treatment of de novo native coronary artery lesions when compared to a paclitaxel-eluting stent, and showed that "low late loss" may be achieved with drug-eluting stents without sacrificing safety.

24 Sep 2009

District court of Frankfurt, Germany rules in favour of Occlutech

Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an earlier court injunction obtained by AGA Medical against Occlutech's sales and marketing activities relating to the newly launched Figulla Flex ranges of ASD and PFO occluders.

24 Sep 2009

Mayo Clinic Health Manager users have access to blood pressure trackers

As part of Mayo Clinic and Microsoft Corp.'s shared vision to help families take better care of their health, the two companies have made enhancements to Mayo Clinic Health Manager, a free online application designed to help people organize and better manage their health. People with conditions such as hypertension and high cholesterol will now have access to a variety of trackers and up-to-date information to help keep their conditions under control.

24 Sep 2009

Clinical trial comparing Boston Scientific's coronary stent systems

Boston Scientific Corporation today welcomed one-year data from the SPIRIT IV clinical trial comparing the XIENCE V((R)) (PROMUS((R))) Everolimus-Eluting Coronary Stent System to the TAXUS((R)) Express2(TM) Paclitaxel-Eluting Coronary Stent System. The results support the benefits of paclitaxel-eluting stents in diabetic patients. The trial enrolled 3,690 patients, including 1,140 diabetics, the largest diabetic subset ever studied in a drug-eluting stent clinical trial.

24 Sep 2009

Growth in demand for Noveko International's antimicrobial products

Noveko International Inc. ("the Company") is pleased to announce that the value of its firm orders for its Noveko(TM) antimicrobial face masks and respirators and AZURO(TM) hand sanitizers, for the period beginning July 1st, 2009, currently totals approximately $18 million, i.e. $12 million for face masks and respirators and $6 million for sanitizers. This significant number of orders reflects the sharp increase in demand for the Company's antimicrobial products. The orders come mainly from various distributors, notably Eval Consulting, BLD Distribution L.L.C., Aerosys Technologies and Medi-Select.

24 Sep 2009

Researchers to discuss ways to develop mathematical control theory methods for ABMs at NIMBioS workshop

Agent-based models (ABMs) are powerful computer-simulation modeling techniques that used increasingly to understand a broad range of biological phenomena, such as tumor growth, the immune system, and the spread of infectious diseases through a population.

24 Sep 2009

Global Med to market the Spanish verIDhemos transfusion safety system

Global Med Technologies(R), Inc. an international healthcare information technology company, today announced that it has signed a binding letter of intent with verIDentia SL of Macanet De La Selva, Girona, Spain for its verIDhemos transfusion safety system. Terms of the agreement were not disclosed.

24 Sep 2009

Pre-clinical data demonstrates advantages of Combo Stent

OrbusNeich announced today that pre-clinical data involving porcine coronary models demonstrate that the company's Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher(R) sirolimus eluting stent and the XIENCE(TM) V everolimus eluting stent.

24 Sep 2009

Clinical study results of Novolimus and Myolimum eluting coronary stent systems released

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today positive results from three multicenter first-in-man studies of Novolimus and Myolimus eluting coronary stent systems with durable and bioabsorbable polymers. Findings were presented at the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT 2009) scientific symposium.

24 Sep 2009

Some imaging centers, drug makers may be driving up costs

The Dallas Morning News reports on the lure of the medical imaging business, which is many say is a "growth industry," including the idea that a "second- or third-hand MRI machine" can be purchased by a physician practice or free-standing imaging center for a few hundred thousand dollars but yield millions in new revenue. A report by America's Health Insurance Plans says as many as half the scans are unnecessary, and a McKinsey Global Institute study found the extra machines produce around $26.4 billion in additional costs each year. In addition, they expose patients to avoidable radiation (McNeill, 9/22).

24 Sep 2009

IM Practice Manager to increase the quality of care

The Hospital of Central Connecticut (THOCC), a 400-bed hospital in New Britain, has chosen Ingenious Med's IM Practice Manager to automate, organize and increase quality of care and revenue. In the first phase, more than 75 physicians at THOCC will be using IM's handheld and Internet-based solution, joining hundreds of other physicians in Connecticut as licensed Ingenious Med users, making it the most widely used electronic charge capture system in the state.

24 Sep 2009

ProCon creates a website for healthcare debate

ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://healthcare.procon.org to explore the core question "Should all Americans have the right (be entitled) to health care?"

24 Sep 2009

New software to be demonstrated at the International CTIA WIRELESS IT & Entertainment 2009

AuthenTec, the world’s leading provider of smart sensor based solutions, announced that it will demonstrate its newest mobile products and software, and will highlight new commercially released phones that incorporate its award-winning technology at International CTIA WIRELESS IT & Entertainment 2009 in San Diego.

24 Sep 2009

Mountain Lakes to implement Netsmart's clinical and practice management behavioral health software solution

Netsmart Technologies, Inc., a leading provider of software and services for health and human services organizations, today announced an agreement to provide its CCHIT-certified clinical and practice management behavioral health software and related services to Mountain Lakes Behavioral Healthcare of Guntersville, Ala

24 Sep 2009

$Cardiogenesis sponsors educational symposium on refractory angina treatment method$

Cardiogenesis sponsors educational symposium on refractory angina treatment method

Cardiogenesis Corporation, a market leader in laser transmyocardial revascularization (TMR), today announced that it sponsored an educational symposium yesterday in conjunction with the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco.

24 Sep 2009

PNNL Department of Energy researcher earns prestigious NIH Director's New Innovator Award

An analytical chemist at the Department of Energy's Pacific Northwest National Laboratory has been recognized with a National Institutes of Health Director's New Innovator Award. The award will support Wei-Jun Qian's drive to make new research and clinical diagnostic tools that are dramatically more sensitive, reliable and faster than current technologies.

24 Sep 2009

New version of Adis R&D Insight global pipeline database launched

Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, today introduced a powerful, new version of its popular Adis R&D Insight global pipeline database.

24 Sep 2009

Online portal for parents of children with disabilities

United Cerebral Palsy (UCP), today announced the launch of My Child Without Limits (MyChildWithoutLimits.org), UCP's pioneering initiative that provides parents of children with disabilities an online resource with critical information that also connects parents to a vital social network of parents of newly diagnosed children ages 0 to 5.

24 Sep 2009

COMPARE trial results demonstrate higher efficacy of XIENCE V stent system

Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS(R) Liberte Paclitaxel-Eluting Coronary Stent System (TAXUS).

24 Sep 2009